BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31659300)

  • 21. Protective Regulatory T Cell Immune Response Induced by Intranasal Immunization With the Live-Attenuated Pneumococcal Vaccine SPY1
    Liao H; Peng X; Gan L; Feng J; Gao Y; Yang S; Hu X; Zhang L; Yin Y; Wang H; Xu X
    Front Immunol; 2018; 9():1754. PubMed ID: 30116243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.
    Moffitt KL; Malley R; Lu YJ
    PLoS One; 2012; 7(8):e43445. PubMed ID: 22905267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.
    Trzciński K; Thompson CM; Srivastava A; Basset A; Malley R; Lipsitch M
    Infect Immun; 2008 Jun; 76(6):2678-84. PubMed ID: 18391006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country.
    Lundgren A; Bhuiyan TR; Novak D; Kaim J; Reske A; Lu YJ; Qadri F; Malley R
    Vaccine; 2012 Jun; 30(26):3897-907. PubMed ID: 22504663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.
    Wang H; Hoffman C; Yang X; Clapp B; Pascual DW
    PLoS Pathog; 2020 Jan; 16(1):e1008176. PubMed ID: 31951645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effector T
    Amezcua Vesely MC; Pallis P; Bielecki P; Low JS; Zhao J; Harman CCD; Kroehling L; Jackson R; Bailis W; Licona-Limón P; Xu H; Iijima N; Pillai PS; Kaplan DH; Weaver CT; Kluger Y; Kowalczyk MS; Iwasaki A; Pereira JP; Esplugues E; Gagliani N; Flavell RA
    Cell; 2019 Aug; 178(5):1176-1188.e15. PubMed ID: 31442406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.
    Malley R; Anderson PW
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3623-7. PubMed ID: 22308483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
    Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
    Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric Subserous Vaccination With
    Liu W; Zeng Z; Luo S; Hu C; Xu N; Huang A; Zheng L; Sundberg EJ; Xi T; Xing Y
    Front Immunol; 2019; 10():1115. PubMed ID: 31156652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.
    Bogaert D; Weinberger D; Thompson C; Lipsitch M; Malley R
    Infect Immun; 2009 Apr; 77(4):1613-22. PubMed ID: 19168741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge.
    Nelson SA; Dileepan T; Rasley A; Jenkins MK; Fischer NO; Sant AJ
    J Virol; 2021 Jul; 95(16):e0084121. PubMed ID: 34076479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
    Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells.
    Haddadi S; Vaseghi-Shanjani M; Yao Y; Afkhami S; D'Agostino MR; Zganiacz A; Jeyanathan M; Xing Z
    Front Immunol; 2019; 10():2075. PubMed ID: 31552032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.
    Lynch JM; Briles DE; Metzger DW
    Infect Immun; 2003 Aug; 71(8):4780-8. PubMed ID: 12874361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
    Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
    Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cells in the pneumococcus-infected lung are heterogeneous and require CD4
    Etesami NS; Barker KA; Shenoy AT; De Ana CL; Arafa EI; Grifno GN; Matschulat AM; Vannini ME; Pihl RMF; Breen MP; Soucy AM; Goltry WN; Ha CT; Betsuyaku H; Browning JL; Varelas X; Traber KE; Jones MR; Quinton LJ; Maglione PJ; Nia HT; Belkina AC; Mizgerd JP
    Front Immunol; 2024; 15():1382638. PubMed ID: 38715601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous IL-1R1 signaling is critical for cognate CD4+ T cell help for induction of in vivo type 1 and type 2 antipolysaccharide and antiprotein Ig isotype responses to intact Streptococcus pneumoniae, but not to a soluble pneumococcal conjugate vaccine.
    Chen Q; Sen G; Snapper CM
    J Immunol; 2006 Nov; 177(9):6044-51. PubMed ID: 17056530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
    Malley R; Srivastava A; Lipsitch M; Thompson CM; Watkins C; Tzianabos A; Anderson PW
    Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.